Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2025 | $224.00 | Outperform → Neutral | Robert W. Baird |
| 3/26/2025 | $200.00 | Equal-Weight | Morgan Stanley |
| 2/3/2025 | Neutral → Overweight | Cantor Fitzgerald | |
| 12/17/2024 | $226.00 | Neutral | Analyst |
| 12/16/2024 | $228.00 → $198.00 | Buy → Neutral | Goldman |
| 11/6/2024 | $223.00 | Neutral | BofA Securities |
| 10/16/2024 | $220.00 → $283.00 | Hold → Buy | TD Cowen |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets |
Robert W. Baird downgraded Universal Health from Outperform to Neutral and set a new price target of $224.00
Morgan Stanley initiated coverage of Universal Health with a rating of Equal-Weight and set a new price target of $200.00
Cantor Fitzgerald upgraded Universal Health from Neutral to Overweight